Fundraising Fox
/People
Sign in

Aravind Asokan

Founder

Founder at Stridebio

Chapel Hill, North Carolina, United States

FoundedStridebio

Find your path to Aravind

205 people in our graph share verified history with Aravind — schools, employers, funds. One of them is your warm intro.

Diana BernsteinunlockedAravind: together at Torque Bio (2022–2024)
×2Aravind: together at Torque Bio
×2Aravind: together at Coave Therapeutics
×4Aravind: together at Kriya Therapeutics

Founder at Stridebio

Intro paths

→

In turn, Aravind can intro founders to Stridebio's investors below.

Stridebio's investors · 4

AbingworthLondon · $15M – $30M checks · since 2018De Novo VenturesBoston · since 2021Hatteras Venture PartnersResearch Triangle · $500K – $4M checks · since 2021Pontifax Venture CapitalHerzeliya · $6.3M – $128M checks

Co-founders at Stridebio

MAMavis Abjandje-McKenna
Mavis Abjandje-McKennaDirector

Experience

  1. Duke UniversityProfessor & Director of Gene Therapy, Department of Surgery, School of Medicinecurrent2018 — presentDurham, North Carolina, United States
  2. Duke UniversityProfessor, Department of Molecular Genetics & Microbiology, School of Medicinecurrent2018 — present
  3. Duke UniversityProfessor, Department of Biomedical Engineering, Pratt School of Engineeringcurrent2018 — present
  4. Duke UniversityNovartis Global Scholar (at Duke University)current2023 — present
  5. The ATG ProjectFounder & Directorcurrent2026 — present
  6. Lucidigm TherapeuticsCo-Founder & Board Directorcurrent2023 — presentUnited States
  7. Danaher Beacon for Gene Therapy Innovation (Partnership with Duke University)Directorcurrent2022 — present
  8. American Society of Gene & Cell TherapyDirector At Largecurrent2022 — present
  9. Torque BioCo-Founder & Board Directorcurrent2022 — present
  10. Nvelop TherapeuticsScientific Advisory Boardcurrent2024 — present
  11. Coave TherapeuticsScientific Advisory Boardcurrent2023 — presentParis, France
  12. Ring TherapeuticsScientific Advisory Boardcurrent2021 — present
  13. Atsena TherapeuticsScientific Advisory Boardcurrent2020 — present
  14. Ginkgo Bioworks, Inc.Advisor2023 — 2024
  15. Mammoth BiosciencesScientific Advisory Board2021 — 2024
  16. Kriya Therapeutics, Inc.Advisor2022 — 2023
  17. Isolere Bio (Acquired by Donaldson Co.)Scientific Advisor2021 — 2023
  18. StrideBio, Inc (Platform acquired by Ginkgo Bioworks)Co-Founder, Board Director & Acting CSO2016 — 2023
  19. WardenBio (Acquired by Kriya Therapeutics)Co-Founder2021 — 2022
  20. UNC Gene Therapy Center, Department of Genetics, Department of Biochemistry & BiophysicsAssociate Professor2014 — 2018
  21. UNC Gene Therapy CenterInterim Director2016
  22. Bamboo Therapeutics (Acquired by Pfizer)Scientific Co-Founder2015
  23. UNC Department of Genetics & Gene Therapy CenterAssistant Professor2008 — 2014

Skills & more

Gene TherapyChemical BiologyVirologyMolecular BiologyProtein EngineeringMolecular CloningAnimal ModelsSite-directed MutagenesisFluorescence MicroscopyqPCRProtein PurificationMolecular Genetics
+6 moreChemistryBiochemistryCell BiologyGeneticsLife SciencesCell Culture

From Aravind's professional profile.

Frequently asked questions

Who is Aravind Asokan?
Director at Stridebio
Where does Aravind Asokan work?
Aravind Asokan is Founder of Stridebio.
What companies did Aravind Asokan found?
Aravind Asokan founded Stridebio.
Where did Aravind Asokan go to school?
Aravind Asokan studied at The University of North Carolina at Chapel Hill (Postdoctoral Fellow, Virology & Gene Therapy); The University of North Carolina at Chapel Hill (Ph.D., Pharmaceutical Chemistry); Birla Institute of Technology and Science, Pilani (Master of Science (M.Sc.), Biological Sciences).

Founder mafias

Same school

Shared employers